NEWS
2025.05.14
Release
ExaWizards Accelerates Sales of AI Services and Products Through Sales Agency Agreement with NTT Communications — Expanding Adoption of Multiple Services such as exaBase Generative AI, exaBase Studio, and exaBase Meeting Summary by Leveraging NTT Com’s Customer Base of 650,000 Companies —
2025.05.13
Release
ExaWizards and COCOO Establish JV to Provide Generative AI Support Services — Leveraging Both Companies’ Strengths to Accelerate the Growth of exaBase Generative AI and Offer Generative AI Services for Business Automation —
2025.05.13
Release
ExaWizards and Sony Life Communications Develop a New Generative AI Service to Create Inspiring Customer Experiences Through Future Visualization – Achieved Through AI-Human Collaboration, Along with the Development of a Lifeplanner Skill Enhancement Application –
2025.05.07
Release
ORIX Life Insurance Implements “exaBase Role Playing” AI Avatars for Effective Training – Harnessing AI for Assessment and Feedback at New Employee Call Center Training, Reducing Senior Trainers’ Workload by 40% –
2025.05.01
Release
ExaWizards Partners with Fukuoka Financial Group to Drive Transformation with AI Agents – Leveraging “exaBase Studio,” an AI Agent Development and Operations Platform, to Co-Create Value and Innovate New Banking Models –
2025.04.24
Release
ExaWizards Enables In-House Development and Operation of Autonomous AI Agents with “exaBase Studio” – Transforming the platform into a hub for creating and nurturing services for office workers, supporting AI agents across the group starting summer 2025 –
2025.04.18
Release
ExaWizards and Tohoku Electric Power Launch Generative AI Services in Tohoku and Niigata — Driving Efficiency and Problem-Solving for Regional Businesses through Tailored AI Solutions —
2025.04.17
Release
Odakyu Electric Railway, a DX-Certified Company, Adopts “exaBase IR Assistant” – Utilizing Generative AI for Operational Efficiency and Maximizing Corporate Value Through Enhanced Disclosures and Dialogue –
2025.04.01
Info
ExaMD, a Member of the ExaWizards Group, obtained the Type II Medical Device Manufacturing and Marketing License, and the Medical Device Sales License – Empowering ExaMD to Develop, Manufacture, and Market Software as a Medical Device (SaMD) –
2025.03.25
Info